Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00323219 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department

StatusCompleted
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Amendment history

  1. Minor

    Trial status: Recruiting to Completed

    Site details revised; Study arms: 0 to 2

    Study Identification, Study Status, Study Design, Arms and Interventions, Contacts/Locationsv6

  2. Minor

    Study Status, Sponsor/Collaborators

    Re-verified, no change to tracked fields

    v5

  3. Notable

    Primary completion date: Dec 2011 to Dec 2012

    Completion date: Dec 2011 to Dec 2013

    Study Statusv4

  4. Notable

    Primary and study completion dates: Dec 2008 to Dec 2011

    Study Statusv3

  5. Minor

    Primary completion date: Dec 2008

    Secondary endpoints: details revised at 1 of 1 entry

    Study Status, Sponsor/Collaborators, Oversight, Study Design, Arms and Interventions, Outcome Measures, Eligibilityv2

  6. Minor

    Study First Submitted

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Patients often come to the emergency department with bacterial skin infections (known as "cellulitis"). Some patients with very severe infections are admitted to hospital for antibiotic treatment and some are sent home on oral antibiotics. Many patients have moderate infections and are treated as outpatients with daily intravenous antibiotics for 2-5 days. In this patient group it is unclear if treatment with oral antibiotics is as effective as intravenous antibiotics. The purpose of this study is to determine if treatment of moderate cellulitis with an intravenous antibiotic (cefazolin) for 3-5 days is as effective as treatment with an oral antibiotic (moxifloxacin). We hypothesize that the oral agent will be as effective as intravenous treatment for moderate cellulitis.
Trial Details
NCT Number NCT00323219
Lead Sponsor University of British Columbia
Conditions Cellulitis
Enrollment 390 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov